New compound for slowing the aging process can lead to novel treatments for brain diseases

A successful collaboration between researchers at the Hebrew university of Jerusalem and the startup company TyrNovo may lead to a potential treatment of brain diseases like Alzheimer's, Parkinson's and Huntington's. The researchers found that TyrNovo’s novel and unique compound, named NT219, selectively inhibits the process of aging in order to protect the brain from neurodegenerative diseases, without affecting lifespan. This is a first and important step towards the development of future drugs.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...